Acadia Healthcare Company, Inc. (ACHC) Form 8-K — Nov 4, 2026
Acadia Healthcare reported Q3 2026 revenue of $895.3 million, up 5.1% year over year, with same-facility revenue growth of 5.2% on 1.1% patient day growth and 4.0% revenue per patient day gains. GAAP net income was $34.5 million ($0.38 diluted EPS), down from $36.2 million ($0.40) a year ago, while Adjusted EBITDA rose 2% to $176.4 million. Adjusted EPS fell 17% to $0.60, and Q3 results included a $13.4 million Florida supplemental payment benefit versus $5.6 million previously guided. The company raised full-year 2026 guidance to $3.44-$3.46 billion in revenue, $615-$625 million Adjusted EBITDA, and $1.70-$1.80 Adjusted EPS.
Key figures
- Eps
- 0.38
- Revenue
- 895300000
- Guidance
- FY2026 revenue $3.44-$3.46B; Adjusted EBITDA $615-$625M; Adjusted EPS $1.70-$1.80; Operating cash flow $375-$400M; Capex $210-$230M
- Net Income
- 34500000
- Revenue Yoy
- 5.1%
- Cash Position
- 163300000
- Adjusted eps
- 0.6
- Net leverage ratio
- 3.9x
- Licensed beds added
- 220
- Adjusted ebitda millions
- 176.4
- Adjusted net income millions
- 54.6
- Same facility revenue growth
- 5.2%
- Revolver availability millions
- 710.1
- Incremental 2027 de novo ebitda millions
- 60
- Florida supplemental payment benefit millions
- 13.4
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.